Kalbe Farma Tbk Stock Buy Hold or Sell Recommendation
| PTKFY Stock | USD 21.05 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Kalbe Farma Tbk is 'Hold'. Macroaxis provides Kalbe Farma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding PTKFY positions. The advice algorithm takes into account all of Kalbe Farma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Kalbe Farma's buy or sell advice are summarized below:
Real Value 21.05 | Hype Value 21.05 | Market Value 21.05 | Naive Value 21.05 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kalbe Farma Tbk given historical horizon and risk tolerance towards Kalbe Farma. When Macroaxis issues a 'buy' or 'sell' recommendation for Kalbe Farma Tbk, the advice is generated through an automated system that utilizes algorithms and statistical models.
Kalbe |
Execute Kalbe Farma Buy or Sell Advice
The Kalbe recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kalbe Farma Tbk. Macroaxis does not own or have any residual interests in Kalbe Farma Tbk or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kalbe Farma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Kalbe Farma Trading Alerts and Improvement Suggestions
| Kalbe Farma Tbk generated a negative expected return over the last 90 days |
Kalbe Farma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kalbe Farma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kalbe Farma's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kalbe pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.00 | |
β | Beta against NYSE Composite | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Kalbe Farma Volatility Alert
At this time Kalbe Farma Tbk exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kalbe Farma's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kalbe Farma's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kalbe Farma Fundamentals Vs Peers
Comparing Kalbe Farma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kalbe Farma's direct or indirect competition across all of the common fundamentals between Kalbe Farma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kalbe Farma or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Kalbe Farma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kalbe Farma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Kalbe Farma to competition |
| Fundamentals | Kalbe Farma | Peer Average |
| Return On Equity | 0.17 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.12 % | (1.27) % |
| Current Valuation | 5.89 B | 16.62 B |
| Shares Outstanding | 231.28 M | 571.82 M |
| Price To Earning | 32.31 X | 28.72 X |
| Price To Book | 4.75 X | 9.51 X |
| Price To Sales | 3.28 X | 11.42 X |
| Revenue | 26.26 T | 9.43 B |
| Gross Profit | 11.11 T | 27.38 B |
| EBITDA | 4.54 T | 3.9 B |
| Net Income | 3.18 T | 570.98 M |
| Cash And Equivalents | 189.29 M | 2.7 B |
| Cash Per Share | 0.81 X | 5.01 X |
| Total Debt | 490.28 B | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 4.08 X | 2.16 X |
| Book Value Per Share | 4.20 X | 1.93 K |
| Cash Flow From Operations | 2.83 T | 971.22 M |
| Earnings Per Share | 0.96 X | 3.12 X |
| Number Of Employees | 12.64 K | 18.84 K |
| Beta | 0.32 | -0.15 |
| Market Capitalization | 7.21 B | 19.03 B |
| Total Asset | 25.67 T | 29.47 B |
| Z Score | 1.0 | 8.72 |
| Annual Yield | 0.03 % | |
| Five Year Return | 1.72 % | |
| Net Asset | 25.67 T |
Kalbe Farma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kalbe . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Kalbe Farma Buy or Sell Advice
When is the right time to buy or sell Kalbe Farma Tbk? Buying financial instruments such as Kalbe Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kalbe Farma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Fabricated Products Thematic Idea Now
Fabricated Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Fabricated Products theme has 11 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Fabricated Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Kalbe Farma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Kalbe Farma Tbk information on this page should be used as a complementary analysis to other Kalbe Farma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Kalbe Pink Sheet analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |